Wyss Institute for Biologically Inspired Engineering

Wyss Institute for Biologically Inspired Engineering
Name	Wyss Institute for Biologically Inspired Engineering
Established	2009
Founder	Hansjörg Wyss
Director	Donald Ingber
Parent	Harvard University
Location	Boston, Massachusetts, United States
Website	https://wyss.harvard.edu/

Wyss Institute for Biologically Inspired Engineering. The Wyss Institute for Biologically Inspired Engineering is a cross-disciplinary research institute at Harvard University focused on developing innovative materials, devices, and robotic systems inspired by biological design principles. Founded in 2009 through a transformative gift from Swiss philanthropist Hansjörg Wyss, its mission is to translate breakthrough insights from nature into transformative technologies that advance healthcare and improve sustainability. The institute operates as a collaborative consortium involving multiple Harvard schools, affiliated hospitals, and partner universities, aiming to bridge the gap between academic discovery and real-world application.

History and mission

The institute was formally launched in 2009 following a historic $125 million donation from entrepreneur and philanthropist Hansjörg Wyss, with foundational support from Harvard University and the Commonwealth of Massachusetts. Its creation was driven by a vision to emulate nature's efficiency and resilience to solve major global challenges in medicine, manufacturing, and environmental stewardship. The founding director, Donald Ingber, a pioneer in biomimetics and cellular mechanobiology, established a unique operational model that emphasizes high-risk, high-reward research. The core mission is to discover the engineering principles used by living systems and harness them to create new technologies, accelerating their translation to commercial products through partnerships with industry and startups.

Research areas and technologies

Research at the institute is organized into collaborative, interdisciplinary platforms that tackle specific grand challenges. Key areas include biomimetic microsystems, where researchers develop human organ-on-a-chip platforms that emulate lung, intestine, and bone marrow functions for drug testing. The field of synthetic biology is leveraged to program living cells for therapeutic and diagnostic applications, while adaptive materials research draws inspiration from phenomena like protein folding to create self-assembling and responsive substances. Additional focal points are molecular robotics, which designs nanoscale devices from DNA origami, and bioinspired robotics, creating machines modeled on the agility of animals like the stick insect for use in search-and-rescue or exploration.

Organizational structure and leadership

The institute is led by Founding Director Donald Ingber, who also holds positions at Harvard Medical School and Boston Children's Hospital. Its research is conducted by a core faculty of over 40 interdisciplinary experts, alongside staff scientists, postdoctoral fellows, and students from across the Harvard University ecosystem, including the Harvard John A. Paulson School of Engineering and Applied Sciences and Harvard Medical School. A distinctive feature is its "Institute Project" model, where teams composed of biologists, clinicians, engineers, and business developers work collaboratively on specific technology translations. Strategic guidance is provided by an external board that includes leaders from academia, venture capital, and industry.

Notable achievements and impact

The institute has produced numerous groundbreaking technologies with significant scientific and commercial impact. Its most recognized innovation is the Human Organs-on-Chips platform, which received the top honor at the Design Museum London's Designs of the Year award and led to the creation of the spin-off company Emulate, Inc.. Other major advances include a novel slip chip for low-cost medical diagnostics, SHERLOCK CRISPR-based diagnostic tools licensed to Sherlock Biosciences, and soft exosuits developed with the United States Department of Defense to augment human mobility. These technologies have generated over 60 commercial licenses, more than 45 startup companies, and a substantial portfolio of patents.

Collaborations and partnerships

Collaboration is central to the institute's model, extending across academia, industry, and government. Within Harvard University, it works closely with affiliated hospitals like Brigham and Women's Hospital and the Dana–Farber Cancer Institute. It maintains strategic alliances with partner universities such as the Massachusetts Institute of Technology, the University of Zurich, and Boston University. Significant industry partnerships have been formed with corporations like Google's Verily Life Sciences and pharmaceutical giants for drug development. The institute also engages in major funded consortia with agencies including the Defense Advanced Research Projects Agency, the National Institutes of Health, and the Food and Drug Administration.

Funding and resources

Initial capitalization was provided by the founding gift from Hansjörg Wyss, which was later augmented by an additional $131 million donation in 2013 to support expansion. The institute sustains its operations through a diversified funding model that includes competitive grants from federal agencies like the National Science Foundation, targeted research contracts from industry partners, and philanthropic support. Its physical resources are housed primarily in state-of-the-art laboratories in the Center for Life Science Boston in the Longwood Medical Area, with additional facilities at Harvard University's Allston campus. This funding ecosystem supports the entire innovation pipeline, from early-stage discovery to technology validation and startup launch.

Category:Harvard University Category:Research institutes in Massachusetts Category:Biotechnology organizations Category:Engineering organizations Category:Organizations established in 2009